Skip to main content

Home/ Cancer/ Group items tagged press

Rss Feed Group items tagged

Matti Narkia

AICR: Policy Report: Policy and Action for Cancer Prevention - 0 views

  •  
    Policy Report\n\nLearn more about the new WCRF/AICR report, Policy and Action for Cancer Prevention, which was launched at an international press briefing in London at 10 a.m. GMT (5 a.m. US Eastern Time), and presented to US lawmakers at a Congressional Briefing at 10 a.m. US Eastern Time, on February 26th, 2009.
Matti Narkia

The DCA Site - Updating You on DCA and Cancer - Dichloroacetic acid and Dichloroacetate - 0 views

  •  
    After the news story in the Belgium press of two terminally ill cancer patients who used DCA and are now on the road to recovery, the Belgium people are asking questions. "It has brought a lot commotion in Belgium. All the people are wondering why they haven't heard from DCA any sooner! And they wonder why it isn't recognized yet as an official medicine for cancer!
Matti Narkia

Integrative Oncology: Donald Abrams and Andrew Weil - Oxford University Press - 0 views

  •  
    Integrative Oncology Donald Abrams and Andrew Weil SBN13: 9780195309447 ISBN10: 0195309448 Hardback, 624 pages Nov 2008, In Stock
Matti Narkia

ANTIFUNGAL DRUG STOPS BLOOD VESSEL GROWTH - 0 views

  •  
    Researchers at Johns Hopkins have discovered to their surprise that a drug commonly used to treat toenail fungus can also block angiogenesis, the growth of new blood vessels commonly seen in cancers. The drug, itraconazole, already is FDA approved for hum
Matti Narkia

Vitamin D Levels Linked to Breast-Cancer Prognosis - GrassrootsHealth | Vitamin D Action - 0 views

  •  
    Women who are vitamin D deficient when they are diagnosed with breast cancer are more likely to have their disease spread and are more likely to die than women who have adequate vitamin D levels, new Canadian research says. The study found that women who were vitamin D deficient were 94 per cent more likely to have their cancer metastasize (spread) and 73 per cent more likely to die. The research was led by Dr. Pamela Goodwin, a breast cancer researcher at Mount Sinai Hospital in Toronto. The study analyzed blood samples and disease outcome from more than 500 women diagnosed with breast cancer between 1989 and 1995. Women were followed up for an average of 11 years.
1 - 6 of 6
Showing 20 items per page